These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2783551)

  • 1. Conformation of high molecular weight kininogen: effects of kallikrein and factor XIa cleavage.
    Villanueva GB; Leung L; Bradford H; Colman RW
    Biochem Biophys Res Commun; 1989 Jan; 158(1):72-9. PubMed ID: 2783551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function.
    Scott CF; Silver LD; Purdon AD; Colman RW
    J Biol Chem; 1985 Sep; 260(19):10856-63. PubMed ID: 3875612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the coagulant activity and surface binding of high molecular weight kininogen.
    Colman RW; Silver LD; Purdon AD; Chang JJ; Scott CF
    Trans Assoc Am Physicians; 1984; 97():113-23. PubMed ID: 6336014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; Colman RW
    Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein.
    Tayeh MA; Olson ST; Shore JD
    J Biol Chem; 1994 Jun; 269(23):16318-25. PubMed ID: 8206938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the participation of the contact system in the Vroman effect. Review and summary.
    Scott CF
    J Biomater Sci Polym Ed; 1991; 2(3):173-81. PubMed ID: 1854683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stoichiometry of binding of high molecular weight kininogen to factor XI/XIa.
    Warn-Cramer BJ; Bajaj SP
    Biochem Biophys Res Commun; 1985 Dec; 133(2):417-22. PubMed ID: 3936495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF; Pixley RA; Colman RW
    Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.
    Donaldson VH; Harrison RA
    Blood; 1982 Jul; 60(1):121-9. PubMed ID: 6211203
    [No Abstract]   [Full Text] [Related]  

  • 12. Human high molecular weight kininogen. Effects of cleavage by kallikrein on protein structure and procoagulant activity.
    Schiffman S; Mannhalter C; Tyner KD
    J Biol Chem; 1980 Jul; 255(13):6433-8. PubMed ID: 6901530
    [No Abstract]   [Full Text] [Related]  

  • 13. Contact activation of factor XI.
    Jacobs A; Mannhalter C; Margalit R; Schiffman S
    Br J Haematol; 1981 Sep; 49(1):77-86. PubMed ID: 7272231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
    Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
    Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
    Maier M; Austen KF; Spragg J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
    Meloni FJ; Gustafson EJ; Schmaier AH
    Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.
    DeLa Cadena RA; Colman RW
    Protein Sci; 1992 Jan; 1(1):151-60. PubMed ID: 1304876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.